Nuwellis (NUWE) Change in Accured Expenses (2011 - 2026)
Nuwellis' (NUWE) quarterly Change in Accured Expenses came in at $348000.0 in Q2 2026, down 69.71% on a YoY basis from $1.1 million in Q2 2025, and down 12.56% quarter-over-quarter from $398000.0 in Q1 2026.
Powered by 
Analysis
Nuwellis (NUWE) Change in Accured Expenses (2011 - 2026) Analysis & Trends
Nuwellis (NUWE) has reported Change in Accured Expenses for 16 consecutive years, with $348000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Change in Accured Expenses fell 69.71% year-over-year to $348000.0; the trailing twelve-month figure through Jun 2026 stood at -$136000.0 (up 18.56% YoY), and the FY2025 full-year result was $406000.0, up 164.86% from the prior year.
- Change in Accured Expenses slipped to $348000.0 in Q2 2026 per NUWE's latest filing, from $398000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $1.2 million in Q1 2024 and bottomed at -$1.3 million in Q3 2024.
- Historically, Change in Accured Expenses has averaged $16888.9 across 5 years, with a median of $58500.0 in 2022.
- The sharpest annual moves came in 2023 and 2025: Change in Accured Expenses plunged 1155.56% in 2023, then jumped 457.94% in 2025.
- Over 5 years, Change in Accured Expenses stood at $1.0 million in 2022, then tumbled by 82.62% to $178000.0 in 2023, then plunged by 178.65% to -$140000.0 in 2024, then plunged by 260.0% to -$504000.0 in 2025, then soared by 169.05% to $348000.0 in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered $348000.0, $398000.0, and -$504000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 55.00 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -531.00 Mn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 298.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 234.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 123.70 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -74.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 112.90 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn | 348,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 348,000.00 |
| Mar 31, 2026 | 398,000.00 |
| Dec 31, 2025 | -504,000.00 |
| Sep 30, 2025 | -378,000.00 |
| Jun 30, 2025 | 1.15 Mn |
| Mar 31, 2025 | 139,000.00 |
| Dec 31, 2024 | -140,000.00 |
| Sep 30, 2024 | -1.32 Mn |
| Jun 30, 2024 | -321,000.00 |
| Mar 31, 2024 | 1.15 Mn |
| Dec 31, 2023 | 178,000.00 |
| Sep 30, 2023 | -822,000.00 |
| Jun 30, 2023 | -286,000.00 |
| Mar 31, 2023 | -570,000.00 |
| Dec 31, 2022 | 1.02 Mn |
| Sep 30, 2022 | 137,000.00 |
| Jun 30, 2022 | 63,000.00 |
| Mar 31, 2022 | 54,000.00 |
| Dec 31, 2021 | -544,000.00 |
| Sep 30, 2021 | 258,000.00 |